D-0574-2025 Class II Ongoing

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0574-2025 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Aug 5, 2025 and is designated Class II. Reason for recall: Presence of foreign substance: identified as aluminum. The recall status is ongoing. Affected quantity: 11,328 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 13, 2025
Initiation Date
Aug 5, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,328 bottles

Product description

Spironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 53489-143-01

Reason for recall

Presence of foreign substance: identified as aluminum.

Distribution pattern

USA Nationwide

Code information

Lot # P3314, Exp 11/30/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0574-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0574-2025. Report a data issue: hello@regdatalab.com.